Our team includes people from 70 different nationalities, speaking more than 45 languages.
Visp is the largest site in a global network of more than 30 sites.
We develop and manufacture more than 170 products every year.
Our Visp site is a complex of industry-leading facilities specializing in the development and manufacture of products for pharmaceutical applications. Products manufactured in Visp include mammalian and microbial biopharmaceuticals, small molecules, highly potent APIs, peptides and bioconjugates including antibody-drug conjugates (ADCs).
It is also home to our pioneering Ibex® Solutions offering. Ibex® Solutions enables customers to accelerate their path throughout the complete biopharmaceutical lifecycle, from preclinical to commercial stages, from drug substance to drug product, all in one location.
We are an industry-leading integrated development and manufacturing CDMO for small molecule drug substances and their intermediates, supporting companies from small biotechs to large pharma. Our wide-ranging capabilities include API process and analytical method development, kilo-lab manufacturing, process transfer, and clinical-scale manufacturing.
We help bring your molecule to life. From early phase to commercial, we have the capacity to deal with different types of molecules with a wide range of OELs. HPAPI manufacture is one of our strengths, and with more than 30 years' experience, we have a leading position in the field, including the manufacture of payloads for bioconjugate products.
Safety, quality, and collaboration are at the core of how we work. Your project is ours, we work as one.
In our extensive contract development and manufacturing services portfolio, we use advanced technologies to quickly and efficiently deliver products such as monoclonal antibodies, complex proteins and recombinant proteins.
Our offering includes preclinical, drug substance and drug product development.
Ibex® Solutions is an innovative concept that provides our customers with a high degree of flexibility and scalability. It’s modular design integrates customer-specific production facilities into an existing building shell with the appropriate infrastructure so that projects can be completed in a fraction of the time. This means that urgently needed medicines can reach patients faster and in sufficient quantities, whether it is a vaccine or a cancer drug.
Lonza’s Ibex® Solutions include Ibex Dedicate, Ibex Design and Ibex Develop solutions.
Sustainability